Christopher H Gu1, David E Lucero1,2, Chaorui C Huang2, Demetre Daskalakis2, Jay K Varma2,3, Neil M Vora2,4. 1. 1 Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA. 2. 2 New York City Department of Health and Mental Hygiene, New York, NY, USA. 3. 3 National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. 4. 4 Career Epidemiology Field Officer Program, Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Abstract
OBJECTIVES: Death certificate data indicate that the age-adjusted death rate for pneumonia and influenza is higher in New York City than in the United States. Most pneumonia and influenza deaths are attributed to pneumonia rather than influenza. Because most pneumonia deaths occur in hospitals, we analyzed hospital discharge data to provide insight into the burden of pneumonia in New York City. METHODS: We analyzed data for New York City residents discharged from New York State hospitals with a principal diagnosis of pneumonia, or a secondary diagnosis of pneumonia if the principal diagnosis was respiratory failure or sepsis, during 2001-2014. We calculated mean annual age-adjusted pneumonia-associated hospitalization rates per 100 000 population and 95% confidence intervals (CIs). We examined data on pneumonia-associated hospitalizations by sociodemographic characteristics and colisted conditions. RESULTS: During 2001-2014, a total of 495 225 patients residing in New York City were hospitalized for pneumonia, corresponding to a mean annual age-adjusted pneumonia-associated hospitalization rate of 433.8 per 100 000 population (95% CI, 429.3-438.3). The proportion of pneumonia-associated hospitalizations with in-hospital death was 12.0%. The mean annual age-adjusted pneumonia-associated hospitalization rate per 100 000 population increased as area-based poverty level increased, whereas the percentage of pneumonia-associated hospitalizations with in-hospital deaths decreased with increasing area-based poverty level. The proportion of pneumonia-associated hospitalizations that colisted an immunocompromising condition increased from 18.7% in 2001 to 33.1% in 2014. CONCLUSION: Sociodemographic factors and immune status appear to play a role in the epidemiology of pneumonia-associated hospitalizations in New York City. Further study of pneumonia-associated hospitalizations in at-risk populations may lead to targeted interventions.
OBJECTIVES: Death certificate data indicate that the age-adjusted death rate for pneumonia and influenza is higher in New York City than in the United States. Most pneumonia and influenza deaths are attributed to pneumonia rather than influenza. Because most pneumonia deaths occur in hospitals, we analyzed hospital discharge data to provide insight into the burden of pneumonia in New York City. METHODS: We analyzed data for New York City residents discharged from New York State hospitals with a principal diagnosis of pneumonia, or a secondary diagnosis of pneumonia if the principal diagnosis was respiratory failure or sepsis, during 2001-2014. We calculated mean annual age-adjusted pneumonia-associated hospitalization rates per 100 000 population and 95% confidence intervals (CIs). We examined data on pneumonia-associated hospitalizations by sociodemographic characteristics and colisted conditions. RESULTS: During 2001-2014, a total of 495 225 patients residing in New York City were hospitalized for pneumonia, corresponding to a mean annual age-adjusted pneumonia-associated hospitalization rate of 433.8 per 100 000 population (95% CI, 429.3-438.3). The proportion of pneumonia-associated hospitalizations with in-hospital death was 12.0%. The mean annual age-adjusted pneumonia-associated hospitalization rate per 100 000 population increased as area-based poverty level increased, whereas the percentage of pneumonia-associated hospitalizations with in-hospital deaths decreased with increasing area-based poverty level. The proportion of pneumonia-associated hospitalizations that colisted an immunocompromising condition increased from 18.7% in 2001 to 33.1% in 2014. CONCLUSION: Sociodemographic factors and immune status appear to play a role in the epidemiology of pneumonia-associated hospitalizations in New York City. Further study of pneumonia-associated hospitalizations in at-risk populations may lead to targeted interventions.
Authors: Christopher W Seymour; Foster Gesten; Hallie C Prescott; Marcus E Friedrich; Theodore J Iwashyna; Gary S Phillips; Stanley Lemeshow; Tiffany Osborn; Kathleen M Terry; Mitchell M Levy Journal: N Engl J Med Date: 2017-05-21 Impact factor: 91.245
Authors: Shannon A Novosad; Mathew R P Sapiano; Cheri Grigg; Jason Lake; Misha Robyn; Ghinwa Dumyati; Christina Felsen; Debra Blog; Elizabeth Dufort; Shelley Zansky; Kathryn Wiedeman; Lacey Avery; Raymund B Dantes; John A Jernigan; Shelley S Magill; Anthony Fiore; Lauren Epstein Journal: MMWR Morb Mortal Wkly Rep Date: 2016-08-26 Impact factor: 17.586
Authors: Robert R German; Aliza K Fink; Melonie Heron; Sherri L Stewart; Chris J Johnson; Jack L Finch; Daixin Yin Journal: Cancer Epidemiol Date: 2010-10-16 Impact factor: 2.984
Authors: Brandon H Hayes; Dana L Haberling; Jordan L Kennedy; Jay K Varma; Alicia M Fry; Neil M Vora Journal: Chest Date: 2017-10-07 Impact factor: 9.410
Authors: Michael L Jackson; Kathleen M Neuzil; William W Thompson; David K Shay; Onchee Yu; Christi A Hanson; Lisa A Jackson Journal: Clin Infect Dis Date: 2004-11-08 Impact factor: 9.079
Authors: Kristin Vardheim Liyanarachi; Erik Solligård; Randi Marie Mohus; Bjørn O Åsvold; Tormod Rogne; Jan Kristian Damås Journal: PLoS One Date: 2022-07-12 Impact factor: 3.752
Authors: Melody Wu; Katherine Whittemore; Chaorui C Huang; Rachel E Corrado; Gretchen M Culp; Sungwoo Lim; Neil W Schluger; Demetre C Daskalakis; David E Lucero; Neil M Vora Journal: PLoS One Date: 2020-12-23 Impact factor: 3.240